Frankfurt - Delayed Quote EUR

Sensorion SA (RFM.F)

Compare
0.6400
-0.0200
(-3.03%)
At close: January 10 at 9:17:53 AM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,743.0640
4,743.0640
4,023.4970
3,335.1990
1,915.4660
Operating Expense
27,013.8910
27,013.8910
27,122.8050
18,336.8090
10,784.3090
Operating Income
-22,270.8270
-22,270.8270
-23,099.3080
-15,001.6100
-8,868.8430
Net Non Operating Interest Income Expense
504.4120
504.4120
-109.7810
-135.1780
-109.2450
Pretax Income
-21,766.4130
-21,766.4130
-23,209.0900
-15,136.7890
-8,978.0890
Tax Provision
296.9910
296.9910
--
--
--
Net Income Common Stockholders
-22,063.4040
-22,063.4040
-23,209.0900
-15,136.7890
-8,978.0890
Diluted NI Available to Com Stockholders
-22,063.4040
-22,063.4040
-23,209.0900
-15,136.7890
-8,978.0890
Basic EPS
-0.17
-0.17
-0.29
-0.19
-0.15
Diluted EPS
-0.17
-0.17
-0.29
-0.19
-0.15
Basic Average Shares
133,422.5580
133,422.5580
79,837.0840
79,691.3580
60,760.9520
Diluted Average Shares
133,422.5580
133,422.5580
79,837.0840
79,691.3580
60,760.9520
Total Operating Income as Reported
-22,310.6280
-22,310.6280
-23,136.6480
-15,024.5970
-8,889.2200
Rent Expense Supplemental
52.0960
52.0960
32.9360
111.7470
117.5190
Total Expenses
27,013.8910
27,013.8910
27,122.8050
18,336.8090
10,784.3090
Net Income from Continuing & Discontinued Operation
-22,063.4040
-22,063.4040
-23,209.0900
-15,136.7890
-8,978.0890
Normalized Income
-22,063.4040
-22,063.4040
-23,209.0900
-15,136.7890
-8,978.0890
Interest Income
718.1130
718.1130
95.5720
53.5520
43.4280
Interest Expense
173.8990
173.8990
168.0140
165.7440
132.2960
Net Interest Income
504.4120
504.4120
-109.7810
-135.1780
-109.2450
EBIT
-21,592.5140
-21,592.5140
-23,041.0760
-14,971.0450
-8,845.7930
EBITDA
-21,326.3200
-21,326.3200
-22,275.1510
-14,475.5270
-8,533.8490
Reconciled Depreciation
266.1940
266.1940
765.9250
495.5180
311.9440
Net Income from Continuing Operation Net Minority Interest
-22,063.4040
-22,063.4040
-23,209.0900
-15,136.7890
-8,978.0890
Normalized EBITDA
-21,326.3200
-21,326.3200
-22,275.1510
-14,475.5270
-8,533.8490
Tax Rate for Calcs
0.0003
0.0003
--
--
--
12/31/2020 - 2/12/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MEDCL.PA MedinCell S.A.
16.48
-2.25%
 
BIOA-B.ST BioArctic AB (publ)
206.80
+1.08%
 
ABVX ABIVAX Société Anonyme
6.38
-4.49%
 
RADX Radiopharm Theranostics Limited
5.35
+30.17%
 
LXEO Lexeo Therapeutics, Inc.
6.39
-6.30%
 
RAPP Rapport Therapeutics, Inc.
14.81
-11.26%
 
NGNE Neurogene Inc.
19.58
-8.89%
 
MBX MBX Biosciences, Inc.
13.69
-5.65%
 
XENE Xenon Pharmaceuticals Inc.
38.41
-2.88%
 
GHRS GH Research PLC
8.57
-4.57%